OMCL - Omnicell, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
81.24
+1.49 (+1.86%)
As of 12:06PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close79.75
Open80.32
Bid80.92 x 800
Ask81.06 x 900
Day's Range79.77 - 81.52
52 Week Range41.59 - 86.87
Volume55,308
Avg. Volume347,239
Market Cap3.314B
Beta (3Y Monthly)1.57
PE Ratio (TTM)87.35
EPS (TTM)0.93
Earnings DateApr 24, 2019 - Apr 29, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est79.75
Trade prices are not sourced from all markets
  • Omnicell Highlighting Importance of Fully Digitized, Autonomous Pharmacy Vision at European Association of Hospital Pharmacists Congress 2019
    PR Newswire4 hours ago

    Omnicell Highlighting Importance of Fully Digitized, Autonomous Pharmacy Vision at European Association of Hospital Pharmacists Congress 2019

    Company to Showcase Advanced Automation to Improve Medication Management MOUNTAIN VIEW, Calif. , March 26, 2019 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management ...

  • Here’s What Omnicell, Inc.’s (NASDAQ:OMCL) P/E Is Telling Us
    Simply Wall St.2 days ago

    Here’s What Omnicell, Inc.’s (NASDAQ:OMCL) P/E Is Telling Us

    This article is for investors who would like to improve their understanding of price to earnings ratios (P/E ratios). We'll show how you can use Omnicell, Inc.'s (NASDAQ:OMCL) P/E ratioRead More...

  • Omnicell's Global Expansion on Track, Stiff Competition Ails
    Zacks8 days ago

    Omnicell's Global Expansion on Track, Stiff Competition Ails

    Although Omnicell (OMCL) is steadily expanding in the Middle East and South African belts, it sees a greater uptake of technologies across other regions of the world.

  • Omnicell (OMCL) Up 27.9% Since Last Earnings Report: Can It Continue?
    Zacks17 days ago

    Omnicell (OMCL) Up 27.9% Since Last Earnings Report: Can It Continue?

    Omnicell (OMCL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Stormont Vail Health Partners with Omnicell to Enhance Medication Management Strategy
    PR Newswire19 days ago

    Stormont Vail Health Partners with Omnicell to Enhance Medication Management Strategy

    MOUNTAIN VIEW, Calif., March 7, 2019 /PRNewswire/ -- Omnicell, Inc. (OMCL) today announced that Stormont Vail Health has selected Omnicell's automated medication management platform to help enhance safety and efficiency in the central pharmacy and patient care areas. The health system will be implementing IV robotics to support an in-house sterile compounding operation, as well as Omnicell® XT Series Automated Dispensing Cabinets to streamline workflows in patient care areas.

  • InvestorPlace19 days ago

    3 Big Stock Charts for Thursday: Omnicell, Advance Auto Parts and LyondellBasell

    The market may not be past the tipping point yet, but yesterday's loss certainly pushes it to the brink. With Wednesday's loss, the S&P 500 is now resting right on its 20-day moving average line, feeling a sentiment headwind.General Electric (NYSE:GE) did much of the damage, losing nearly 8% of its value as investors continue to digest its lackluster cash flow outlook for the year now underway. Advanced Micro Devices (NASDAQ:AMD) took a big bite out of the market too, though, just because increasingly nervous investors continue to file out of their most aggressive trades.There were some winners too. Roku (NASDAQ:ROKU) jumped 4.5% thanks to Guggenheim's improved price target, while Abercrombie & Fitch (NYSE:ANF) bolted more than 20% higher following an earnings report that suggests the retailer may be salvaged after all.InvestorPlace - Stock Market News, Stock Advice & Trading TipsThere just weren't enough of the right, big names to push the market into positive territory.Headed into Thursday's session, the stock charts of Advance Auto Parts (NYSE:AAP), LyondellBasell Industries (NYSE:LYB) and Omnicell (NASDAQ:OMCL) are your better trading bets. Here's why. Omnicell (OMCL)Omnicell has been on fire since the middle part of last year, even sidestepping the worst of December's marketwide weakness to fight its way to record highs earlier this month. * 9 Trade War Stocks to Sell on U.S.-China Deal News All good things must eventually come to an end though, even if only temporarily. As rewarding as OMCL has been of late, we're now seeing all the telltale signs that a pullback from an overbought condition is already underway. Click to Enlarge • The daily chart speaks for itself. While it catapulted higher early last month, the stock has struggled to hold onto those gains. Wednesday's loss was particularly big.• It's not something that can be plotted, but the divergence between the white 200-day moving average line and the stock's price reached a typical maximum of 35% last month, essentially matching September's and November's pre-pullback divergence.• Zooming out to a weekly chart we can see Omnicell has moved into overbought territory with its RSI and stochastic indicators, leaving it ripe for a pullback as has been the case with past clues of the same. A pullback to the 200-day average around $67 may be required to burn off all the froth. Advance Auto Parts (AAP)Advance Auto Parts shares haven't reached their breaking point yet, but they're getting close. As of yesterday's action, a key technical floor is being tested for a second time this year. This time, however, it's starting that test in the shadow of a major bearish clue. Click to Enlarge • The technical support in question is the 200-day moving average line, plotted in white on both stock charts. Any move lower from here would pull AAP below that long-term line for the first time since 2017.• Such a breakdown may already be a foregone conclusion. The tall reversal bar from Feb. 19, highlighted on the daily chart, suggests the pivot has already been made from a net-bullish to a net-bearish environment.• Though the stage is set, it's a setup that practically requires a break below the 200-day moving average line before becoming actionable. LyondellBasell Industries (LYB)We put LyondellBasell Industries on the radar back in early February, when it started to act like it was going to work its way out of a downtrend. It wasn't quite ready for prime-time at the time, but it was inching closer.That potential breakout move never really went anywhere. But, after Wednesday's session, LyondellBasell are closer to a breakout thrust than they've been in months. One more good day could seal the deal. Click to Enlarge • The "setup" is the horizontal trading range that has taken shape since the beginning of the year. The upper edge of that range is plotted in yellow on both stock charts, while the lower boundary is plotted in blue.• Although LYB stock didn't poke through the upper ceiling yet, as of Wednesday, the stock's above the gray 100-day moving average line for the first time in weeks.• Underscoring the new-found bullishness is the volume surge behind yesterday's gain. The bulls had been waiting in the wings, but the swell of volume suggests there's a crowd of willing buyers on standby.As of this writing, James Brumley did not hold a position in any of the aforementioned securities. You can learn more about James at his site, jamesbrumley.com, or follow him on Twitter, at @jbrumley. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 9 Blue-Chip Stocks That Will Lose You Money * 7 Cheap Stocks Under $5 That Could Soar * 7 Stocks Under $10 You Shouldn't Buy Compare Brokers The post 3 Big Stock Charts for Thursday: Omnicell, Advance Auto Parts and LyondellBasell appeared first on InvestorPlace.

  • GuruFocus.com27 days ago

    Omnicell Inc (OMCL) Files 10-K for the Fiscal Year Ended on December 31, 2018

    Omnicell Inc provides automation and business analytics software solutions for patient-centric medication and supplies management across the entire healthcare continuum, from the acute care hospital setting to post-acute skilled nursing. Omnicell Inc had annual average EBITDA growth of 16.50% over the past ten years. GuruFocus rated Omnicell Inc the business predictability rank of 3-star.

  • GlobeNewswirelast month

    Factors of Influence in 2019, Key Indicators and Opportunity within Procter & Gamble, Hertz Global, NN, Omnicell, BioDelivery Sciences International, and Movado Group — New Research Emphasizes Economic Growth

    NEW YORK, Feb. 19, 2019 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.

  • Need To Know: Omnicell, Inc. (NASDAQ:OMCL) Insiders Have Been Selling Shares
    Simply Wall St.last month

    Need To Know: Omnicell, Inc. (NASDAQ:OMCL) Insiders Have Been Selling Shares

    Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! It is not uncommon to see companiesRead More...

  • Omnicell to Feature Vision for Fully Digitized, Autonomous Pharmacy at HIMSS19
    PR Newswirelast month

    Omnicell to Feature Vision for Fully Digitized, Autonomous Pharmacy at HIMSS19

    Technology, Intelligence, and Expert Services Showcased in Booth #2071 Designed to Address Rising Medication Management Costs MOUNTAIN VIEW, Calif. , Feb. 11, 2019 /PRNewswire/ -- Omnicell, Inc., (NASDAQ: ...

  • Thomson Reuters StreetEventslast month

    Edited Transcript of OMCL earnings conference call or presentation 7-Feb-19 9:30pm GMT

    Q4 2018 Omnicell Inc Earnings Call

  • Omnicell (OMCL) Q4 Earnings Beat Estimates, Revenues Miss
    Zacks2 months ago

    Omnicell (OMCL) Q4 Earnings Beat Estimates, Revenues Miss

    Omnicell (OMCL) steadily benefits from product introductions, strategic alliances and digital conversions.

  • Omnicell Inc (OMCL) Q4 2018 Earnings Conference Call Transcript
    Motley Fool2 months ago

    Omnicell Inc (OMCL) Q4 2018 Earnings Conference Call Transcript

    OMCL earnings call for the period ending December 31, 2018.

  • Omnicell (OMCL) Q4 Earnings Surpass Estimates
    Zacks2 months ago

    Omnicell (OMCL) Q4 Earnings Surpass Estimates

    Omnicell (OMCL) delivered earnings and revenue surprises of 4.48% and -1.35%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

  • Cerner: Latest Results and Big Investment Group Signal It's a Buy
    GuruFocus.com2 months ago

    Cerner: Latest Results and Big Investment Group Signal It's a Buy

    Investors seeking stocks to short may want to look closely at the companies in health care information technology. Warning! GuruFocus has detected 2 Warning Sign with CERN. Although the report didn't cite companies, maybe one of candidates trading higher than warranted is Cerner Corp. (CERN).

  • Associated Press2 months ago

    Omnicell: 4Q Earnings Snapshot

    On a per-share basis, the Mountain View, California-based company said it had net income of 36 cents. Earnings, adjusted for one-time gains and costs, came to 70 cents per share. The results beat Wall ...

  • PR Newswire2 months ago

    Omnicell Reports Results for Fiscal Year and Fourth Quarter 2018

    Record yearly GAAP revenues of $787.3 million Record yearly Non-GAAP revenues of $787.3 million 2018 GAAP net income per diluted share of $0.93 Record 2018 Non-GAAP net income per diluted share of $2.09 ...

  • Omnicell Solid on Geographic Expansion Amid Stiff Competition
    Zacks2 months ago

    Omnicell Solid on Geographic Expansion Amid Stiff Competition

    Omnicell (OMCL) gains from expanding into new markets. Stiff rivalry is a concern.

  • Omnicell's Automated Medication Dispensing System Receives Top KLAS Award for the 13th Consecutive Year
    PR Newswire2 months ago

    Omnicell's Automated Medication Dispensing System Receives Top KLAS Award for the 13th Consecutive Year

    Company Also Sweeps Category Leader Designations for Central Pharmacy Automation Hardware MOUNTAIN VIEW, Calif. , Feb. 4, 2019 /PRNewswire/ --  Omnicell, Inc. , (NASDAQ: OMCL), has earned top honors in ...

  • Omnicell to Release Fourth Quarter 2018 Earnings Results on February 7, 2019
    PR Newswire2 months ago

    Omnicell to Release Fourth Quarter 2018 Earnings Results on February 7, 2019

    MOUNTAIN VIEW, Calif. , Feb. 1, 2019 /PRNewswire/  --  Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and adherence tools for healthcare systems and pharmacies, ...

  • Omnicell (OMCL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
    Zacks2 months ago

    Omnicell (OMCL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

    Omnicell (OMCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Illumina (ILMN) Q4 Earnings Lag Estimates, Revenues Top Mark
    Zacks2 months ago

    Illumina (ILMN) Q4 Earnings Lag Estimates, Revenues Top Mark

    Illumina's (ILMN) Q4 figures show a sturdy uptick in sequencing consumable revenues.

  • Texas Children's Hospital Expands Partnership with Omnicell
    PR Newswire2 months ago

    Texas Children's Hospital Expands Partnership with Omnicell

    According to an American Society of Health-system Pharmacists national survey, pharmacy directors estimate that 76 percent of staff time is spent on non-clinical activities.1 An automated medication management infrastructure empowers pharmacists, nurses, clinicians, and pharmacy staff to focus on patient and clinician satisfaction, leading to improved patient care, fewer errors, enhanced safety, and new opportunities for growth. "As our health system continues to expand, we are constantly striving for excellence in care across our facilities," said Gee Mathen, assistant director of Pharmacy Applications and Technical Services at Texas Children's Hospital.

  • Thermo Fisher (TMO) Down on Business Divestment Declaration
    Zacks2 months ago

    Thermo Fisher (TMO) Down on Business Divestment Declaration

    Thermo Fisher's (TMO) Anatomical Pathology business comes under its Specialty Diagnostics segment catering to customers at healthcare and clinical laboratories.

  • Here's Why You Should Snap Up Abbott (ABT) Stock Right Now
    Zacks2 months ago

    Here's Why You Should Snap Up Abbott (ABT) Stock Right Now

    We are optimistic about the strong and consistent performance of Abbott's (ABT) EPD segment. The company's Diabetes Care business has been hogging the limelight on strength in FreeStyle Libre.